Neoproteomics
Neoproteomics is a Uppsala-based biotechnology company developing a next-generation sequencing system for cancer diagnostics using biomarkers from platelets.
1
Funding Rounds
$100.0k
Money raised
Overview
Neoproteomics is a Uppsala-based biotechnology company developing a next-generation sequencing system for cancer diagnostics using biomarkers from platelets.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Neoproteomics has raised a total of $100k in funding over 1 rounds.
Key Insights:
- Neoproteomics Seed round, February 2011: $100k
Neoproteomics Seed round, February 2011
$100k